October 10, 2011
MSD K.K. launched Cubicin 350 mg for IV Injection (daptomycin) on September 22 as a treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections. Cubicin was approved in 73 countries as of September. Its NHI price is set at ¥13,154 per 350...read more